| Title | Date | PubMed ID |
|---|
| Standardization of α-L-iduronidase enzyme assay with Michaelis-Menten kinetics. | 2014 Feb | 24332804 |
| Human α-L-iduronidase uses its own N-glycan as a substrate-binding and catalytic module. | 2013 Sep 3 | 23959878 |
| Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients. | 2013 Aug | 23786846 |
| Characterization of α-l-Iduronidase (Aldurazyme®) and its complexes. | 2013 Mar 27 | 23026551 |
| Crystallization, X-ray diffraction analysis and SIRAS phasing of human α-L-iduronidase. | 2012 Nov 1 | 23143250 |
| Recombinant encapsulated cells overexpressing alpha-L-iduronidase correct enzyme deficiency in human mucopolysaccharidosis type I cells. | 2012 | 21778683 |
| Biodistribution and pharmacodynamics of recombinant human alpha-L-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations. | 2011 Jul | 21482164 |
| Three novel α-L-iduronidase mutations in 10 unrelated Chinese mucopolysaccharidosis type I families. | 2011 Apr | 21734815 |
| Cognitive and neuroradiological improvement in three patients with attenuated MPS I treated by laronidase. | 2010 May | 20106688 |
| Efficacy of recombinant human alpha-L-iduronidase (laronidase) on restricted range of motion of upper extremities in mucopolysaccharidosis type I patients. | 2010 Apr | 20217237 |